2023 Q3 Form 10-Q Financial Statement

#000143774923032000 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $100.0K
YoY Change -97.42%
Cost Of Revenue $80.28K
YoY Change -96.08%
Gross Profit $19.74K
YoY Change -98.92%
Gross Profit Margin 19.74%
Selling, General & Admin $2.565M
YoY Change 49.73%
% of Gross Profit 12995.39%
Research & Development $46.73K
YoY Change 86.94%
% of Gross Profit 236.74%
Depreciation & Amortization $34.19K
YoY Change 79.08%
% of Gross Profit 173.2%
Operating Expenses $6.004M
YoY Change 245.39%
Operating Profit -$5.985M
YoY Change -6220.28%
Interest Expense -$2.647K
YoY Change -108.76%
% of Operating Profit
Other Income/Expense, Net -$3.886K
YoY Change -113.42%
Pretax Income -$5.988M
YoY Change -4824.63%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.988M
YoY Change -4824.63%
Net Earnings / Revenue -5986.99%
Basic Earnings Per Share -$0.40
Diluted Earnings Per Share -$0.40
COMMON SHARES
Basic Shares Outstanding 15.11M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $879.0K
YoY Change -80.89%
Cash & Equivalents $879.0K
Short-Term Investments $0.00
Other Short-Term Assets $162.7K
YoY Change -97.09%
Inventory $6.882M
Prepaid Expenses $909.8K
Receivables $1.624M
Other Receivables $0.00
Total Short-Term Assets $13.59M
YoY Change -37.04%
LONG-TERM ASSETS
Property, Plant & Equipment $356.3K
YoY Change 16.57%
Goodwill $11.29M
YoY Change -78.19%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $183.4K
YoY Change 133.97%
Total Long-Term Assets $11.83M
YoY Change -77.32%
TOTAL ASSETS
Total Short-Term Assets $13.59M
Total Long-Term Assets $11.83M
Total Assets $25.42M
YoY Change -65.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $739.2K
YoY Change 357.6%
Accrued Expenses $411.3K
YoY Change -64.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $476.5K
YoY Change 1636.52%
Total Short-Term Liabilities $1.627M
YoY Change 21.15%
LONG-TERM LIABILITIES
Long-Term Debt $13.02K
YoY Change -28.58%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $13.02K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.627M
Total Long-Term Liabilities $13.02K
Total Liabilities $1.640M
YoY Change 20.48%
SHAREHOLDERS EQUITY
Retained Earnings -$61.44M
YoY Change 432.62%
Common Stock $151.00
YoY Change 0.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.78M
YoY Change
Total Liabilities & Shareholders Equity $25.42M
YoY Change -65.53%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$5.988M
YoY Change -4824.63%
Depreciation, Depletion And Amortization $34.19K
YoY Change 79.08%
Cash From Operating Activities -$969.6K
YoY Change -41.07%
INVESTING ACTIVITIES
Capital Expenditures -$3.670K
YoY Change -90.27%
Acquisitions
YoY Change
Other Investing Activities $1.013M
YoY Change 2686.57%
Cash From Investing Activities $1.016M
YoY Change -72693.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.160K
YoY Change 496.23%
NET CHANGE
Cash From Operating Activities -969.6K
Cash From Investing Activities 1.016M
Cash From Financing Activities -3.160K
Net Change In Cash 43.57K
YoY Change -102.64%
FREE CASH FLOW
Cash From Operating Activities -$969.6K
Capital Expenditures -$3.670K
Free Cash Flow -$965.9K
YoY Change -39.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
271218 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
271218 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15106088
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15106088
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15021088
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15021088
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
2336402 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
5671326 usd
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38078
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0774222
dei Entity Address Address Line1
EntityAddressAddressLine1
1425 Ohlendorf Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Osceola
dei Entity Address State Or Province
EntityAddressStateOrProvince
AR
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
72370
dei City Area Code
CityAreaCode
870
dei Local Phone Number
LocalPhoneNumber
970-3355
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
EVTV
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15106088
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
879042 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2765068 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
60399 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
2336402 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1624369 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2073691 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
6882247 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
5671326 usd
CY2023Q3 evtv Inventory Deposits
InventoryDeposits
3133753 usd
CY2022Q4 evtv Inventory Deposits
InventoryDeposits
4829933 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
909847 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
445963 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
162695 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
156457 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
13591953 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
18339239 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
356271 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368461 usd
CY2023Q3 us-gaap Goodwill
Goodwill
11290491 usd
CY2022Q4 us-gaap Goodwill
Goodwill
14682620 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183369 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
93369 usd
CY2023Q3 us-gaap Assets
Assets
25422084 usd
CY2022Q4 us-gaap Assets
Assets
33483689 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
739236 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
603744 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
411323 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
652528 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
476497 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
215766 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1627056 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1472038 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
13024 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
16671 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1640080 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1488709 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
151 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
150 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85220733 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83923350 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61438880 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51928520 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
23782004 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31994980 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25422084 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33483689 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
100024 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1029280 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2756103 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2625090 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
80283 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
677855 usd
us-gaap Cost Of Revenue
CostOfRevenue
1739005 usd
us-gaap Cost Of Revenue
CostOfRevenue
1599290 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
19741 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
351425 usd
us-gaap Gross Profit
GrossProfit
1017098 usd
us-gaap Gross Profit
GrossProfit
1025800 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2578727 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1584973 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6785405 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6113957 usd
CY2023Q3 evtv Consulting Expense
ConsultingExpense
-13312 usd
CY2022Q3 evtv Consulting Expense
ConsultingExpense
94187 usd
evtv Consulting Expense
ConsultingExpense
207930 usd
evtv Consulting Expense
ConsultingExpense
264505 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46734 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
175546 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
112412 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3392129 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3392129 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
6004278 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1704160 usd
us-gaap Operating Expenses
OperatingExpenses
10561010 usd
us-gaap Operating Expenses
OperatingExpenses
6490874 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5984537 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1352735 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9543912 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5465074 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2647 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
30200 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
43455 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
37956 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1239 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1233 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9903 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10094 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3886 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28967 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
33552 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27862 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5988423 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1323768 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9510360 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5437212 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5988423 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-158265 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
90272 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1323768 usd
us-gaap Net Income Loss
NetIncomeLoss
-9510360 usd
us-gaap Net Income Loss
NetIncomeLoss
-5437212 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15068208
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15013236
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15036967
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14981836
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31994980 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87144 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2267908 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
29814216 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
105166 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1254029 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28665353 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1105074 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5988423 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
23782004 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
73741864 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
120000 usd
CY2022Q1 evtv Stock Issued During Period Value Legal Settlements
StockIssuedDuringPeriodValueLegalSettlements
197431 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1614845 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2936862 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
72737278 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1176582 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
71560696 usd
CY2022Q3 evtv Stock Issued During Period Value Legal Settlements
StockIssuedDuringPeriodValueLegalSettlements
125000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1323768 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
70361928 usd
us-gaap Net Income Loss
NetIncomeLoss
-9510360 usd
us-gaap Net Income Loss
NetIncomeLoss
-5437212 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
93737 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
56700 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-9903 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
6033 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1297384 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1614845 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3392129 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-449322 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1956906 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1210921 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2103834 usd
evtv Increase Decrease In Inventory Deposits
IncreaseDecreaseInInventoryDeposits
-1696180 usd
evtv Increase Decrease In Inventory Deposits
IncreaseDecreaseInInventoryDeposits
351970 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3190 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
377107 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
112382 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-76919 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-238030 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-194907 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
403328 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4039576 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8271750 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36331 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
90204 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
-0 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
2291036 usd
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2342643 usd
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
8323461 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2306312 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5942221 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
120000 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-213161 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-13766 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-213161 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
106234 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1946425 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2223295 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2825467 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4906525 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
879042 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2683230 usd
us-gaap Interest Paid Net
InterestPaidNet
5808 usd
us-gaap Interest Paid Net
InterestPaidNet
2272 usd
evtv Stock Issued For Services
StockIssuedForServices
1 usd
evtv Stock Issued For Services
StockIssuedForServices
0 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
322431 usd
us-gaap Nature Of Operations
NatureOfOperations
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em></b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Organization and Operations</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-align: justify;">Envirotech Vehicles, Inc. (“we”, “us”, “our” or the “Company”) is a provider of purpose-built <em style="font: inherit;">zero</em>-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies, and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles. The Company’s vehicles address the challenges of traditional fuel price cost instability and local, state, and federal regulatory compliance.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-align: justify;">On <em style="font: inherit;"> February 22, 2022, </em>the Company announced Osceola, Arkansas, as the site of its state-of-the-art manufacturing facility and new corporate offices. The Company has moved into an approximately 580,000 square foot facility.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-align: justify;">On <em style="font: inherit;"> June 28, 2022, </em>we effected a 20-for-<em style="font: inherit;">1</em> stock split of our common stock with <em style="font: inherit;">no</em> change to authorized shares of common stock. All share, restricted stock unit (“RSU”), and per share or per RSU information through this Quarterly Report on Form <em style="font: inherit;">10</em>-Q has been retroactively adjusted to reflect the stock split. The shares of common stock retain a par value of $0.00001 per share. Accordingly, an amount equal to the par value of the decreased shares resulting from the reverse stock split was reclassified from “Common Stock” to “Additional paid-in capital.”</p>
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-align: justify;"><b><i>Use of Estimates</i></b>—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions<b><i> </i></b>that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
60399 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1895587 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
271218 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1624369 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2344909 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
271218 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2073691 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6894676 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
6882247 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5683755 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
12429 usd
CY2023Q3 evtv Inventory Deposits
InventoryDeposits
3133753 usd
CY2022Q4 evtv Inventory Deposits
InventoryDeposits
4829933 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1207888
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1389584
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-align: justify;"><i><b>Concentration of Credit Risk</b></i>—The Company has credit risks related to cash and cash equivalents on deposit with a federally insured bank, as at times it exceeds the <em style="font: inherit;">$250,000</em> maximum amount insured by the Federal Deposit Insurance Corporation (“FDIC”). Additionally, the Company maintains cash and short-term securities invested at Arvest Bank, National Association (“Arvest”). Between FDIC and the Securities Investor Protection Corporation (“SIPC”) coverage, funds up to $750,000, which <em style="font: inherit;"> may </em>include cash up to $500,000, are insured. In addition, Arvest provides excess insurance acquired by them from SIPC for unlimited per customer securities up to a $1 billion cap.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q3 evtv Maximum Insured Funds Fdic And Spic
MaximumInsuredFundsFdicAndSpic
750000 usd
CY2023Q3 evtv Maximum Cash Insured
MaximumCashInsured
500000 usd
CY2023Q3 evtv Extra Insurance By Spic Cap Unlimited Per Customer Securities
ExtraInsuranceBySpicCapUnlimitedPerCustomerSecurities
1000000000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46734 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
175546 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
112412 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1105074 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1297384 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1614845 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
695166 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
613618 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
338895 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
245157 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
356271 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368461 usd
CY2023Q3 us-gaap Depreciation
Depreciation
34192 usd
us-gaap Depreciation
Depreciation
93737 usd
CY2022Q3 us-gaap Depreciation
Depreciation
19093 usd
us-gaap Depreciation
Depreciation
56700 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1389584
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
17.43
evtv Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualLife
P2Y11M4D
evtv Class Of Warrants Or Rights Expired During Period
ClassOfWarrantsOrRightsExpiredDuringPeriod
12833
CY2023Q3 evtv Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
608266
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.3
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M7D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1207888
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M26D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1194971
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
374913 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
191363 usd
CY2023Q3 evtv Lessee Operating Lease Liability To Be Paid Year Two And Three
LesseeOperatingLeaseLiabilityToBePaidYearTwoAndThree
183550 usd
CY2023Q3 evtv Lessee Operating Lease Liability To Be Paid Year Four And Five
LesseeOperatingLeaseLiabilityToBePaidYearFourAndFive
0 usd
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
374913 usd
CY2023Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
191363 usd
CY2023Q3 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
183550 usd
CY2023Q3 us-gaap Contractual Obligation Due In Fourth And Fifth Year
ContractualObligationDueInFourthAndFifthYear
0 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
59857 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
177397 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
52579 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
180746 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
0 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
56101 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
177397 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
124645 usd
us-gaap Lease Cost
LeaseCost
177397 usd
us-gaap Lease Cost
LeaseCost
180746 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
56890 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y7M13D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.14 pure

Files In Submission

Name View Source Status
0001437749-23-032000-index-headers.html Edgar Link pending
0001437749-23-032000-index.html Edgar Link pending
0001437749-23-032000.txt Edgar Link pending
0001437749-23-032000-xbrl.zip Edgar Link pending
adom20230930_10q.htm Edgar Link pending
evtv-20230930.xsd Edgar Link pending
evtv-20230930_cal.xml Edgar Link unprocessable
evtv-20230930_def.xml Edgar Link unprocessable
adom20230930_10q_htm.xml Edgar Link completed
evtv-20230930_pre.xml Edgar Link unprocessable
ex_582645.htm Edgar Link pending
ex_582646.htm Edgar Link pending
ex_582647.htm Edgar Link pending
ex_582648.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
evtv-20230930_lab.xml Edgar Link unprocessable